First Time Loading...

Palla Pharma Ltd
ASX:PAL

Watchlist Manager
Palla Pharma Ltd Logo
Palla Pharma Ltd
ASX:PAL
Watchlist
Price: 0.295 AUD Market Closed
Updated: May 21, 2024

Net Margin
Palla Pharma Ltd

-349.5%
Current
-86%
Average
0.4%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-349.5%
=
Net Income
-58.8m
/
Revenue
16.8m

Net Margin Across Competitors

Country AU
Market Cap 47.8m AUD
Net Margin
-349%
Country US
Market Cap 224.3B USD
Net Margin
14%
Country US
Market Cap 197.4B USD
Net Margin
18%
Country US
Market Cap 45B USD
Net Margin
18%
Country US
Market Cap 41.5B USD
Net Margin
9%
Country KR
Market Cap 55.4T KRW
Net Margin
23%
Country CH
Market Cap 37B CHF
Net Margin
10%
Country US
Market Cap 32.3B USD
Net Margin
21%
Country IE
Market Cap 26.1B USD
Net Margin
8%
Country US
Market Cap 24.7B USD
Net Margin
19%
Country US
Market Cap 20.8B USD
Net Margin
21%

Profitability Report

View the profitability report to see the full profitability analysis for Palla Pharma Ltd.

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-349.5%
=
Net Income
-58.8m
/
Revenue
16.8m
What is the Net Margin of Palla Pharma Ltd?

Based on Palla Pharma Ltd's most recent financial statements, the company has Net Margin of -349.5%.